The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CDK4/6 inhibitors and hormone therapy in hormone receptor-positive advanced breast cancer: Real-world data and intrinsic subtypes defined by PAM50.
 
Tamara Diaz Redondo
No Relationships to Disclose
 
Rocío Lavado-Valenzuela
No Relationships to Disclose
 
Maria Emilia Dominguez-Recio
No Relationships to Disclose
 
Sofía Ruíz
No Relationships to Disclose
 
Encarnación González Flores
No Relationships to Disclose
 
Jose Antonio Lopez-Lopez
No Relationships to Disclose
 
Vanessa de Luque
No Relationships to Disclose
 
Cristina Morales-Estevez
No Relationships to Disclose
 
Marta Robles-Lasarte
No Relationships to Disclose
 
Jesus Perales-Adan
No Relationships to Disclose
 
Enrique Saez Lara
No Relationships to Disclose
 
Martina Alvarez
No Relationships to Disclose
 
Alfonso Sanchez-Muñoz
No Relationships to Disclose
 
Ana Godoy
No Relationships to Disclose
 
Ester Villar
No Relationships to Disclose
 
Francisco Carabantes
No Relationships to Disclose
 
Jose Manuel Baena-Cañada
Consulting or Advisory Role - Eisai; Grunenthal; Novartis; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - MSD Oncology; Pfizer; Roche Pharma AG
 
Jose Manuel Jerez
No Relationships to Disclose
 
Nuria Ribelles
Research Funding - Pfizer (Inst)
 
Emilio Alba
Consulting or Advisory Role - Bristol-Myers Squibb; Genomic Health; Lilly; NanoString Technologies; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Merck Sharp & Dohme